ReviewFrontiers in immunology2025

METTL16 emerges as a pivotal epitranscriptomic regulator, linking RNA modification, tumor progression, and immune modulation.

Qiang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.